"Should I get proton therapy?" is a question that my patients often ask me, and you may be thinking about it right now. The short answer is that "it depends." Only you and your oncologist should be making this decision.
Recent findings published in the Journal of Clinical Oncology suggest that aspirin may play a role in reducing the recurrence of breast cancer in women who have been treated for that disease.
When cancer and heart disease - the leading cause of death in men and women worldwide - are combined, managing both conditions can be challenging for both patients and doctors.
Dr. John Mendelsohn, president of the MD Anderson Cancer Center in Houston, Texas, says that when he was born, only a third of cancer patients lived five years or more. Now, two-thirds live that long.
Women with breast cancer who eat more soy are less likely to die or have a recurrence of cancer than women who eat few or no soy products, according to a new study.
New drugs and new combinations under development bring a targeted approach to improving care for chronic lymphocytic leukemia (CLL) and for overcoming drug-resistant chronic myeloid leukemia (CML).
Annual Report Shows Overall Decline in U.S. Cancer Incidence and Death Rates; Feature Focuses on Cancers with Recent Increasing Trends
The new study, appearing in Cancer Prevention Research, suggests that people most at risk of developing oral cancer may benefit from taking green tea extract, especially in higher doses.
Cancer eludes, suppresses or subverts the body's immune system to survive and grow. Scientists at M. D. Anderson have found that the helper T cell Th17 awakens the immune system to attack and destroy tumors with custom-made killer T cells.
The study found that about 59 percent of people taking the highest dose of the green tea extract showed a clinical response, compared with 18 percent of those who took a placebo.
Women with a relatively uncommon type of breast cancer are significantly more likely to face its recurrence and spread, but researchers now say these women may benefit from treatment with the breast cancer drug Herceptin.
For the grand opening of the newly-expanded Ferragamo store in the Galleria last week, the Italian leather goods house brought in a slew of fancy footwear and bags from the Ferragamo Creations collection, a to-die-for group of iconic designs from the company's archives.
With more than 17,000 employees and warrens of color-coded hallways so vast that even employees get lost, M. D. Anderson is its own parallel universe, where nothing matters but cancer. Patients sit in the lobbies and compare notes.
A study led by Grace Li Smith, M.D., Ph.D., in M. D. Anderson's Department of Radiation Oncology, compares the use of lumpectomy to that of the other surgical option available to women with early invasive disease, mastectomy.
Cancerwise is not a member of any groups.
Latest Comments